Observational analysis highlights Th17/Treg imbalance affecting ocular surface in chronic allergic conjunctivitis, suggesting a novel therapeutic approach.
Substance P contributes to persistent AC by disrupting the Th17/Treg equilibrium via STAT3/STAT5 signaling, thereby exacerbating ocular surface damage. Targeting the SP/NK1R pathway may offer a novel therapeutic approach for chronic AC.
No takes yet. Share an insight, caveat, or question.
Bao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: